SLC9C1
gene geneOn this page
Also known as NHE
Summary
SLC9C1 (solute carrier family 9 member C1, HGNC:31401) is a protein-coding gene on chromosome 3q13.2, encoding Solute carrier family 9 member C1 (Q4G0N8). Sperm-specific solute carrier involved in intracellular pH regulation of spermatozoa.
Predicted to enable potassium:proton antiporter activity and sodium:proton antiporter activity. Predicted to be involved in potassium ion transmembrane transport; regulation of intracellular pH; and sodium ion import across plasma membrane. Predicted to act upstream of or within flagellated sperm motility. Predicted to be located in membrane and motile cilium. Predicted to be active in plasma membrane.
Source: NCBI Gene 285335 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 167 total
- MANE Select transcript:
NM_183061
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:31401 |
| Approved symbol | SLC9C1 |
| Name | solute carrier family 9 member C1 |
| Location | 3q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | NHE |
| Ensembl gene | ENSG00000172139 |
| Ensembl biotype | protein_coding |
| OMIM | 612738 |
| Entrez | 285335 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 protein_coding, 2 nonsense_mediated_decay
ENST00000305815, ENST00000467397, ENST00000471295, ENST00000486574, ENST00000487372
RefSeq mRNA: 2 — MANE Select: NM_183061
NM_001320531, NM_183061
CCDS: CCDS33817, CCDS82818
Canonical transcript exons
ENST00000305815 — 29 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001157253 | 112208178 | 112208373 |
| ENSE00001175621 | 112243995 | 112244076 |
| ENSE00001200195 | 112262924 | 112263098 |
| ENSE00001200197 | 112264200 | 112264343 |
| ENSE00001200198 | 112266238 | 112266340 |
| ENSE00001386738 | 112204218 | 112204403 |
| ENSE00001498081 | 112140898 | 112141281 |
| ENSE00001498085 | 112269916 | 112270077 |
| ENSE00001498086 | 112274897 | 112275025 |
| ENSE00001498087 | 112277695 | 112277860 |
| ENSE00001952047 | 112294093 | 112294216 |
| ENSE00003466931 | 112179531 | 112179701 |
| ENSE00003469904 | 112168877 | 112169062 |
| ENSE00003490498 | 112182133 | 112182258 |
| ENSE00003490771 | 112169197 | 112169328 |
| ENSE00003500618 | 112217442 | 112217561 |
| ENSE00003524954 | 112167221 | 112167347 |
| ENSE00003530010 | 112221128 | 112221225 |
| ENSE00003541958 | 112154997 | 112155049 |
| ENSE00003563036 | 112239840 | 112240006 |
| ENSE00003565112 | 112199321 | 112199469 |
| ENSE00003565380 | 112280683 | 112280783 |
| ENSE00003584304 | 112202250 | 112202399 |
| ENSE00003596373 | 112278729 | 112278857 |
| ENSE00003602183 | 112200711 | 112200762 |
| ENSE00003611348 | 112151857 | 112151963 |
| ENSE00003614804 | 112180564 | 112180662 |
| ENSE00003625875 | 112231361 | 112231486 |
| ENSE00003674515 | 112286704 | 112286878 |
Expression profiles
Bgee: expression breadth broad, 86 present calls, max score 79.82.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2260 / max 43.0908, expressed in 70 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 43731 | 0.1963 | 60 |
| 43732 | 0.0297 | 7 |
Top tissues by expression
112 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.82 | gold quality |
| body of pancreas | UBERON:0001150 | 68.28 | gold quality |
| testis | UBERON:0000473 | 67.70 | gold quality |
| left testis | UBERON:0004533 | 66.35 | gold quality |
| right testis | UBERON:0004534 | 65.60 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 65.39 | gold quality |
| pancreas | UBERON:0001264 | 63.34 | gold quality |
| skin of abdomen | UBERON:0001416 | 62.04 | gold quality |
| zone of skin | UBERON:0000014 | 61.69 | gold quality |
| skin of leg | UBERON:0001511 | 61.36 | gold quality |
| heart left ventricle | UBERON:0002084 | 60.73 | gold quality |
| apex of heart | UBERON:0002098 | 59.64 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 57.14 | gold quality |
| islet of Langerhans | UBERON:0000006 | 56.62 | gold quality |
| thyroid gland | UBERON:0002046 | 56.61 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 55.28 | gold quality |
| heart | UBERON:0000948 | 55.09 | gold quality |
| calcaneal tendon | UBERON:0003701 | 55.03 | gold quality |
| body of stomach | UBERON:0001161 | 54.97 | gold quality |
| stomach | UBERON:0000945 | 54.61 | gold quality |
| rectum | UBERON:0001052 | 53.61 | gold quality |
| right uterine tube | UBERON:0001302 | 52.52 | gold quality |
| gall bladder | UBERON:0002110 | 52.07 | gold quality |
| duodenum | UBERON:0002114 | 51.80 | gold quality |
| metanephros cortex | UBERON:0010533 | 51.77 | gold quality |
| adrenal tissue | UBERON:0018303 | 51.18 | gold quality |
| cortex of kidney | UBERON:0001225 | 50.70 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 50.58 | gold quality |
| lung | UBERON:0002048 | 50.47 | gold quality |
| kidney | UBERON:0002113 | 50.37 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.25 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): MYC
miRNA regulators (miRDB)
32 targeting SLC9C1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-29A-3P | 100.00 | 73.11 | 1835 |
| HSA-MIR-29B-3P | 100.00 | 73.18 | 1833 |
| HSA-MIR-29C-3P | 100.00 | 73.15 | 1833 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-499A-5P | 99.98 | 70.79 | 1323 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-5682 | 99.89 | 72.56 | 1005 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-544A | 99.84 | 68.66 | 1965 |
| HSA-MIR-374C-5P | 99.80 | 72.06 | 2910 |
| HSA-MIR-655-3P | 99.80 | 72.19 | 2909 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-7157-5P | 99.66 | 69.33 | 1829 |
| HSA-MIR-4310 | 99.59 | 68.84 | 2527 |
| HSA-MIR-449B-3P | 99.20 | 67.24 | 1047 |
| HSA-MIR-548L | 99.06 | 70.90 | 2560 |
| HSA-MIR-6830-5P | 99.01 | 68.73 | 1884 |
| HSA-MIR-6512-5P | 98.76 | 69.29 | 1195 |
| HSA-MIR-9500 | 98.62 | 66.54 | 1845 |
| HSA-MIR-1248 | 98.47 | 67.54 | 1314 |
| HSA-MIR-135A-2-3P | 98.40 | 66.74 | 442 |
| HSA-MIR-135B-3P | 98.40 | 67.35 | 426 |
| HSA-MIR-561-5P | 98.25 | 68.13 | 1365 |
Literature-anchored findings (GeneRIF, showing 2)
- this review outlines the contribution of NHE to chronic complications of diabetes mellitus, such as diabetic nephropathy; diabetic cardiomyopathy.[review] (PMID:23000155)
- The sodium/proton exchanger SLC9C1 (sNHE) is essential for human sperm motility and fertility. (PMID:33462806)
Cross-species orthologs
8 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Slc9c1 | ENSMUSG00000033210 |
| rattus_norvegicus | Slc9c1 | ENSRNOG00000022007 |
| drosophila_melanogaster | Nhe3 | FBGN0028703 |
| drosophila_melanogaster | Nhe2 | FBGN0040297 |
| caenorhabditis_elegans | WBGENE00003730 | |
| caenorhabditis_elegans | WBGENE00003732 | |
| caenorhabditis_elegans | WBGENE00003733 | |
| caenorhabditis_elegans | WBGENE00003734 |
Paralogs (10): SLC9A7 (ENSG00000065923), SLC9A3 (ENSG00000066230), SLC9A1 (ENSG00000090020), SLC9A2 (ENSG00000115616), SLC9A5 (ENSG00000135740), SLC9C2 (ENSG00000162753), SLC9A4 (ENSG00000180251), SLC9A9 (ENSG00000181804), SLC9A8 (ENSG00000197818), SLC9A6 (ENSG00000198689)
Protein
Protein identifiers
Solute carrier family 9 member C1 — Q4G0N8 (reviewed: Q4G0N8)
Alternative names: Na(+)/H(+) exchanger 10, Sodium/hydrogen exchanger 10, Solute carrier family 9 member 10, Sperm-specific Na(+)/H(+) exchanger
All UniProt accessions (4): Q4G0N8, A0AAA9YHL5, C9J3M6, F8WCJ0
UniProt curated annotations — full annotation on UniProt →
Function. Sperm-specific solute carrier involved in intracellular pH regulation of spermatozoa. Required for sperm motility and fertility. Involved in sperm cell hyperactivation, a step needed for sperm motility which is essential late in the preparation of sperm for fertilization. Required for the expression and bicarbonate regulation of the soluble adenylyl cyclase (sAC).
Subunit / interactions. Interacts with soluble adenylyl cyclase (sAC).
Subcellular location. Cell projection. Cilium. Flagellum membrane.
Tissue specificity. Sperm.
Domain organisation. The ion transport-like region is related to the membrane segments of voltage-gated ion channels. Its function is unknown.
Similarity. Belongs to the monovalent cation:proton antiporter 1 (CPA1) transporter (TC 2.A.36) family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q4G0N8-1 | 1 | yes |
| Q4G0N8-2 | 2 |
RefSeq proteins (2): NP_001307460, NP_898884* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000595 | cNMP-bd_dom | Domain |
| IPR005821 | Ion_trans_dom | Domain |
| IPR006153 | Cation/H_exchanger_TM | Domain |
| IPR014710 | RmlC-like_jellyroll | Homologous_superfamily |
| IPR018422 | Cation/H_exchanger_CPA1 | Family |
| IPR018490 | cNMP-bd_dom_sf | Homologous_superfamily |
| IPR027359 | Volt_channel_dom_sf | Homologous_superfamily |
Pfam: PF00027, PF00520, PF00999
UniProt features (52 total): topological domain 18, transmembrane region 17, sequence variant 9, region of interest 3, sequence conflict 3, chain 1, splice variant 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9YDF | X-RAY DIFFRACTION | 2.18 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q4G0N8-F1 | 74.66 | 0.09 |
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-2672351 | Stimuli-sensing channels |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-983712 | Ion channel transport |
MSigDB gene sets: 71 (showing top):
GOBP_POTASSIUM_ION_TRANSPORT, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, GOBP_MALE_GAMETE_GENERATION, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOMF_PROTON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOBP_REGULATION_OF_PH, GOBP_MONOATOMIC_ION_HOMEOSTASIS, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, GOBP_IMPORT_INTO_CELL, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_SODIUM_ION_TRANSPORT, GOCC_MOTILE_CILIUM, GOBP_HOMEOSTATIC_PROCESS
GO Biological Process (12): spermatogenesis (GO:0007283), cell differentiation (GO:0030154), flagellated sperm motility (GO:0030317), regulation of intracellular pH (GO:0051453), potassium ion transmembrane transport (GO:0071805), sodium ion import across plasma membrane (GO:0098719), monoatomic ion transport (GO:0006811), monoatomic cation transport (GO:0006812), sodium ion transport (GO:0006814), sodium ion transmembrane transport (GO:0035725), transmembrane transport (GO:0055085), proton transmembrane transport (GO:1902600)
GO Molecular Function (4): monoatomic ion channel activity (GO:0005216), sodium:proton antiporter activity (GO:0015385), potassium:proton antiporter activity (GO:0015386), antiporter activity (GO:0015297)
GO Cellular Component (5): plasma membrane (GO:0005886), motile cilium (GO:0031514), cilium (GO:0005929), membrane (GO:0016020), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Ion channel transport | 1 |
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| monoatomic cation transmembrane transport | 3 |
| transport | 2 |
| metal cation:proton antiporter activity | 2 |
| cellular anatomical structure | 2 |
| developmental process involved in reproduction | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| regulation of pH | 1 |
| intracellular monoatomic cation homeostasis | 1 |
| regulation of biological quality | 1 |
| potassium ion transport | 1 |
| sodium ion transmembrane transport | 1 |
| inorganic cation import across plasma membrane | 1 |
| monoatomic ion transport | 1 |
| metal ion transport | 1 |
| sodium ion transport | 1 |
| cellular process | 1 |
| monoatomic ion transmembrane transporter activity | 1 |
| channel activity | 1 |
| sodium ion transmembrane transporter activity | 1 |
| solute:potassium antiporter activity | 1 |
| secondary active transmembrane transporter activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cilium | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
696 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC9C1 | SLC9A1 | P19634 | 925 |
| SLC9C1 | ADCY10 | Q96PN6 | 752 |
| SLC9C1 | LGALS1 | P09382 | 717 |
| SLC9C1 | SLC9B1 | Q4ZJI4 | 707 |
| SLC9C1 | KCNU1 | A8MYU2 | 687 |
| SLC9C1 | SLC9A5 | Q14940 | 645 |
| SLC9C1 | SLC9B2 | Q86UD5 | 637 |
| SLC9C1 | SLC9A6 | Q92581 | 598 |
| SLC9C1 | CATSPER1 | Q8NEC5 | 582 |
| SLC9C1 | HVCN1 | Q96D96 | 581 |
| SLC9C1 | SLC9A9 | Q8IVB4 | 543 |
| SLC9C1 | SLC9A8 | Q9Y2E8 | 530 |
| SLC9C1 | CATSPER3 | Q86XQ3 | 525 |
| SLC9C1 | NOMO2 | Q5JPE7 | 507 |
| SLC9C1 | NOMO3 | P69849 | 506 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPAG5 | PLK1 | psi-mi:“MI:0914”(association) | 0.510 |
| SLC9C1 | PSMD12 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC9C1 | SPAG5 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (26): SPAG5 (Affinity Capture-MS), SLC9C1 (Affinity Capture-MS), ADRM1 (Affinity Capture-MS), AMFR (Affinity Capture-MS), BAG2 (Affinity Capture-MS), BAG5 (Affinity Capture-MS), DNAJB1 (Affinity Capture-MS), HERC3 (Affinity Capture-MS), NLRX1 (Affinity Capture-MS), NPLOC4 (Affinity Capture-MS), PPM1L (Affinity Capture-MS), PSMA3 (Affinity Capture-MS), PSMB1 (Affinity Capture-MS), PSMB3 (Affinity Capture-MS), PSMC6 (Affinity Capture-MS)
ESM2 similar proteins: A1Z7R6, A6NIM6, A6QNW6, A9JTG4, A9X4U2, E1BPQ3, F4I9E1, F4KIL8, F5H094, G3V0H7, O35913, O80436, O94911, Q497L8, Q497L9, Q4G0N8, Q4R445, Q5BIZ0, Q5BK75, Q5TAH2, Q5XGZ9, Q68EU6, Q6DBX0, Q6TAC4, Q6UJY2, Q7SXB7, Q86UG4, Q8C0X7, Q8CBB2, Q8IUA7, Q8K440, Q8K441, Q8K442, Q8K449, Q8N139, Q8R0C3, Q8R0S9, Q8WWZ4, Q924V4, Q96RN1
Diamond homologs: A2APX8, A2ASI5, B1AWN6, B1AYL1, D0E0C2, F1LQQ7, O08562, O42398, O46669, O73706, O73707, O88420, O88457, P02719, P04774, P04775, P08104, P0DMA5, P15389, P15390, P35498, P35499, P35500, Q01118, Q05973, Q14524, Q15858, Q20JQ7, Q28371, Q28644, Q2XVR3, Q2XVR4, Q2XVR5, Q2XVR6, Q2XVR7, Q4G0N8, Q62205, Q62968, Q6QIY3, Q99250
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
167 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 136 |
| Likely benign | 15 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4276 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:112141293:G:T | acceptor_gain | 1.0000 |
| 3:112154995:ACCT:A | donor_gain | 1.0000 |
| 3:112154996:CCTC:C | donor_gain | 1.0000 |
| 3:112154998:T:TA | donor_gain | 1.0000 |
| 3:112199040:A:AC | donor_gain | 1.0000 |
| 3:112199041:C:CC | donor_gain | 1.0000 |
| 3:112199316:CTTA:C | donor_loss | 1.0000 |
| 3:112199318:TA:T | donor_loss | 1.0000 |
| 3:112199319:A:C | donor_loss | 1.0000 |
| 3:112199320:C:CG | donor_loss | 1.0000 |
| 3:112199466:TAGC:T | acceptor_gain | 1.0000 |
| 3:112199470:C:CA | acceptor_loss | 1.0000 |
| 3:112199470:C:CC | acceptor_gain | 1.0000 |
| 3:112200760:CAT:C | acceptor_gain | 1.0000 |
| 3:112231359:A:AC | donor_gain | 1.0000 |
| 3:112231360:C:CC | donor_gain | 1.0000 |
| 3:112239838:A:AC | donor_gain | 1.0000 |
| 3:112239839:C:CA | donor_loss | 1.0000 |
| 3:112239839:C:CC | donor_gain | 1.0000 |
| 3:112266236:A:AC | donor_gain | 1.0000 |
| 3:112266237:C:CG | donor_gain | 1.0000 |
| 3:112266237:CT:C | donor_gain | 1.0000 |
| 3:112141277:CTTTC:C | acceptor_gain | 0.9900 |
| 3:112141281:CCTAA:C | acceptor_gain | 0.9900 |
| 3:112141285:A:C | acceptor_gain | 0.9900 |
| 3:112141292:C:CT | acceptor_gain | 0.9900 |
| 3:112141962:T:TA | donor_gain | 0.9900 |
| 3:112154992:TTTAC:T | donor_loss | 0.9900 |
| 3:112154993:TTACC:T | donor_loss | 0.9900 |
| 3:112154994:TAC:T | donor_loss | 0.9900 |
AlphaMissense
7839 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:112270034:A:C | S219R | 0.994 |
| 3:112270034:A:T | S219R | 0.994 |
| 3:112270036:T:G | S219R | 0.994 |
| 3:112182171:A:G | W871R | 0.989 |
| 3:112182171:A:T | W871R | 0.989 |
| 3:112239884:A:G | W468R | 0.981 |
| 3:112239884:A:T | W468R | 0.981 |
| 3:112169256:A:G | W998R | 0.979 |
| 3:112169256:A:T | W998R | 0.979 |
| 3:112199392:C:G | A818P | 0.977 |
| 3:112239882:C:A | W468C | 0.977 |
| 3:112239882:C:G | W468C | 0.977 |
| 3:112179546:G:C | C968W | 0.974 |
| 3:112263011:A:C | S370R | 0.972 |
| 3:112263011:A:T | S370R | 0.972 |
| 3:112263013:T:G | S370R | 0.972 |
| 3:112264290:C:T | G311E | 0.970 |
| 3:112270023:C:T | G223E | 0.969 |
| 3:112221220:G:C | S526R | 0.967 |
| 3:112221220:G:T | S526R | 0.967 |
| 3:112221222:T:G | S526R | 0.967 |
| 3:112277735:A:C | S148R | 0.964 |
| 3:112277735:A:T | S148R | 0.964 |
| 3:112277737:T:G | S148R | 0.964 |
| 3:112270024:C:G | G223R | 0.963 |
| 3:112270024:C:T | G223R | 0.963 |
| 3:112208325:A:C | F613L | 0.962 |
| 3:112208325:A:T | F613L | 0.962 |
| 3:112208327:A:G | F613L | 0.962 |
| 3:112280721:C:G | G51R | 0.959 |
dbSNP variants (sampled 300 via entrez): RS1000014739 (3:112262863 T>C), RS1000054531 (3:112164942 C>A), RS1000079085 (3:112187332 T>C), RS1000084980 (3:112264434 T>A,C), RS1000088579 (3:112164764 T>C), RS1000094199 (3:112211563 C>T), RS1000107097 (3:112228383 T>C,G), RS1000129787 (3:112255903 C>G), RS1000157233 (3:112193797 T>C), RS1000164802 (3:112212462 A>C,G), RS1000180218 (3:112212883 C>G), RS1000250616 (3:112213078 A>T), RS1000266929 (3:112283002 A>C), RS1000285870 (3:112223548 T>A), RS1000319497 (3:112283354 G>C)
Disease associations
OMIM: gene MIM:612738 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004606_113 | Eosinophil count | 1.000000e-09 |
| GCST004623_140 | Neutrophil percentage of granulocytes | 1.000000e-09 |
| GCST004624_47 | Sum eosinophil basophil counts | 8.000000e-11 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004842 | eosinophil count |
| EFO:0007994 | neutrophil percentage of granulocytes |
| EFO:0005090 | basophil count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — SLC9 family of sodium/hydrogen exchangers
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | decreases expression, increases methylation | 2 |
| Benzo(a)pyrene | increases methylation | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Lactic Acid | increases expression | 1 |
| Permethrin | decreases expression | 1 |
Cellosaurus cell lines
2 cell lines: 2 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_TP35 | HAP1 SLC9C1 (-) 1 | Cancer cell line | Male |
| CVCL_TP36 | HAP1 SLC9C1 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.